Ambys Medicines is a brand dedicated to addressing the urgent need for alternate therapies and advancements in the treatment of liver disease. With over 4. 5 million people in the US living with diagnosed liver disease, and more than 11,000 individuals currently on the organ transplant waitlist for a liver, the demand for innovative solutions is evident.

Each year, approximately 9,000 people receive liver transplants, but the number of people in need exceeds this supply. A healthy liver is essential for various bodily functions, and when it fails, transplantation becomes the only curative option. However, the availability of high-quality primary human hepatocytes, crucial for liver assist devices, transplantation, cell therapy, and gene therapy, remains limited.

Current treatments for liver disease are insufficient, with over 50,000 liver-related deaths in the US annually. Ambys Medicines aims to bridge this gap by providing cutting-edge therapies and tools that advance liver disease treatments. Through their dedicated team and scientific expertise, they are committed to making a profound impact on the lives of patients suffering from liver disease.

Contact Ambys Medicines today to learn more about their groundbreaking work in this critical field